Document is current
Any future updates will be listed below
-
Authors
Medina, Frank A.
Dubosq-Lebaz, Maxime
Kim, Joseph M.
Secemsky, Eric A.
-
Funding
Funding for this research was provided by:
Sarnoff Cardiovascular Research Foundation
National Institutes of Health (T32 HL160522)
National Heart, Lung, and Blood Institute (NHLBI K23HL150290)
- License Information
-
More Information
Article History
Accepted: 11 April 2025
First Online: 23 April 2025
Declarations
:
: Dr. Secemsky has received research funding from NHLBI K23HL150290, BD, Vascular Graft Solutions, Philips, Boston Scientific, Abbott, Medtronic, Cook Medical, SCAI, Food and Drug Administration; consulting fees from Boston Scientific, BD, Evident, Endovascular Engineering, Cook, Cagent, Conavi, Abbott, Cordis, InfraRex, Medtronic, Philips, RapidAI, Shockwave, VentureMed, Veryan; and holds leadership roles with VIVA Foundation, Society for Vascular Medicine, and PERT Consortium.
: All reported studies/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional/national research committee standards, and international/national/institutional guidelines).
